Berkovitch M - Search Results

1

Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator.

Matsui D, Hermann C, Klein J, Berkovitch M, Olivieri N, Koren G. Matsui D, et al. Among authors: berkovitch m. J Clin Pharmacol. 1994 Sep;34(9):944-9. doi: 10.1002/j.1552-4604.1994.tb04009.x. J Clin Pharmacol. 1994. PMID: 7983239 Clinical Trial.

2

Use of a eutectic mixture of local anesthetics for prolonged subcutaneous drug administration.

Berkovitch M, Davis S, Matsui D, Donsky J, Koren G, Olivieri NF. Berkovitch M, et al. J Clin Pharmacol. 1995 Mar;35(3):295-7. doi: 10.1002/j.1552-4604.1995.tb04062.x. J Clin Pharmacol. 1995. PMID: 7608320 Clinical Trial.

3

Iron-chelation therapy with oral deferiprone in patients with thalassemia major.

Olivieri NF, Brittenham GM, Matsui D, Berkovitch M, Blendis LM, Cameron RG, McClelland RA, Liu PP, Templeton DM, Koren G. Olivieri NF, et al. Among authors: berkovitch m. N Engl J Med. 1995 Apr 6;332(14):918-22. doi: 10.1056/NEJM199504063321404. N Engl J Med. 1995. PMID: 7877649 Free article. Clinical Trial.

4

Efficacy of deferiprone in the treatment of acute iron intoxication in rats.

Fassos FF, Berkovitch M, Daneman N, Koren L, Cameron RG, Klein J, Falcitelli C, St Louis P, Daneman R, Koren G. Fassos FF, et al. Among authors: berkovitch m. J Toxicol Clin Toxicol. 1996;34(3):279-87. doi: 10.3109/15563659609013790. J Toxicol Clin Toxicol. 1996. PMID: 8667465

5

Salivary measurement of deferiprone concentrations and correlation with serum levels.

Pope E, Berkovitch M, Klein J, Fassos F, Koren G. Pope E, et al. Among authors: berkovitch m. Ther Drug Monit. 1997 Feb;19(1):95-7. doi: 10.1097/00007691-199702000-00018. Ther Drug Monit. 1997. PMID: 9029756 Clinical Trial.

6

Evaluation of therapeutic drug monitoring of methotrexate in saliva of children with rheumatic diseases.

Press J, Berkovitch M, Laxer R, Giesbrecht E, Verjee Z, Silverman E, Klein J, Koren G. Press J, et al. Among authors: berkovitch m. Ther Drug Monit. 1995 Jun;17(3):247-50. doi: 10.1097/00007691-199506000-00006. Ther Drug Monit. 1995. PMID: 7624920

7

Pemoline-associated fulminant liver failure: testing the evidence for causation.

Berkovitch M, Pope E, Phillips J, Koren G. Berkovitch M, et al. Clin Pharmacol Ther. 1995 Jun;57(6):696-8. doi: 10.1016/0009-9236(95)90233-3. Clin Pharmacol Ther. 1995. PMID: 7781270 Review.

8

Arthropathy in thalassaemia patients receiving deferiprone.

Berkovitch M, Laxer RM, Inman R, Koren G, Pritzker KP, Fritzler MJ, Olivieri NF. Berkovitch M, et al. Lancet. 1994 Jun 11;343(8911):1471-2. doi: 10.1016/s0140-6736(94)92585-2. Lancet. 1994. PMID: 7911181

9

Pediatric clinical use of the ketoconazole/cyclosporin interaction.

Berkovitch M, Bitzan M, Matsui D, Finkelstein H, Balfe JW, Koren G. Berkovitch M, et al. Pediatr Nephrol. 1994 Aug;8(4):492-3. doi: 10.1007/BF00856546. Pediatr Nephrol. 1994. PMID: 7947046

10

Recent increases in numbers and risk of fatalities in young children ingesting iron preparations.

Berkovitch M, Matsui D, Lamm SH, Rosa F, Koren G. Berkovitch M, et al. Vet Hum Toxicol. 1994 Feb;36(1):53-5. Vet Hum Toxicol. 1994. PMID: 8154104

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters